Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome? EDITORIAL COMMENT

被引:0
|
作者
Hill, Melissa [1 ,2 ]
Barrett, Angela [3 ]
Choolani, Mahesh [3 ]
Lewis, Celine [1 ,2 ]
Fisher, Jane [4 ]
Chitty, Lyn S. [1 ,2 ]
机构
[1] UCL Great Ormond St Inst Child Hlth, Genet & Genom Med, London, England
[2] Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet Serv, London, England
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore
[4] Antenatal Results & Choices, London, England
关键词
D O I
10.1097/01.ogx.0000534154.01991.cc
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Noninvasive prenatal testing (NIPT) for aneuploidy using cell-free DNA (cfDNA) has become widely available and popular for detection of Down syndrome (DS) because of its high sensitivity (99%) and specificity (99.5%). The acceptance of NIPT as an alternative to the first-trimester combined test has greatly reduced the use of invasive prenatal diagnostic testing. Widespread implementation of NIPT may result in an increase in parents opting for prenatal testing and subsequent reduction in those born with DS as pregnancies are terminated following a high-risk result. This literature review aimed to determine the impact that the introduction of NIPT has had on the number of parents choosing to continue their pregnancy following detection of DS. A systematic search of articles related to NIPTand published from when NIPT entered clinical practice (January 1, 2011, to September 25, 2017) was conducted using the PubMed database. A separate, similar search was conducted to establish country-specific abortion rates prior to the introduction of NIPT. Two audits on termination rates following detection of high risk for DS by NIPT, calculated as a proportion of all pregnancies, were conducted in the United Kingdom and Singapore. A total of 14 studies were included in review. The studies' objectives and design were diverse, 8 prospective and 6 retrospective, whereas only 1 aimed to determine pregnancy outcome and patient decision making following NIPT. The data showed that a significant proportion of pregnancies where NIPT indicated a high risk of DS were continued to live birth in the United States, the United Kingdom, and the Netherlands, whereas there were no live births with DS in the studies from China, Hong Kong, Taiwan, France, and Spain. The audit in Singapore found that 2 of 6 pregnancies were continued to live birth following a high-risk NIPT result, whereas the UK audit found 15 of 43 continued the pregnancy. This study found that many pregnancies were continued to live birth despite receiving a high-risk diagnosis for DS using NIPT. The results also found that the rate of abortion since the clinical implementation of NIPT is unchanged or slightly decreased compared with historical rates. There were numerous instances of women receiving a high-risk result from NIPT and declining to undergo confirmatory invasive testing. These situations suggest some women's intent to undergo NIPT for the sake of obtaining information about the health of their child, however, and unwillingness to risk miscarriage or pursue termination despite the results. Participant numbers were low in many of the studies included, weakening the ability of this review to draw an association between modern and historical termination rates. Larger-scale population-based studies are needed to determine the effect of NIPT on the rates of children born with DS.
引用
收藏
页码:269 / 270
页数:2
相关论文
共 9 条
  • [1] Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
    Hill, Melissa
    Barrett, Angela
    Choolani, Mahesh
    Lewis, Celine
    Fisher, Jane
    Chitty, Lyn S.
    PRENATAL DIAGNOSIS, 2017, 37 (13) : 1281 - 1290
  • [2] THE IMPACT OF LEGAL TERMINATION OF PREGNANCY AND OF PRENATAL-DIAGNOSIS ON THE BIRTH PREVALENCE OF DOWN SYNDROME IN DENMARK
    MIKKELSEN, M
    FISCHER, G
    HANSEN, J
    PILGAARD, B
    NIELSEN, J
    ANNALS OF HUMAN GENETICS, 1983, 47 (MAY) : 123 - 131
  • [3] Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?
    Raaby, Line
    Lou, Stina
    Ivarsen, Rikke Ramlov Lodberg
    Sorensen, Jette
    Larsen, Ole Halfdan
    Vogel, Ida
    PRENATAL DIAGNOSIS, 2024, 44 (03) : 280 - 288
  • [4] A Cost-Effectiveness Analysis Comparing Different Strategies to Implement Noninvasive Prenatal Testing Into a Down Syndrome Screening Program EDITORIAL COMMENT
    Caughey, Aaron B.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (02) : 63 - 65
  • [5] Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy
    Kim, Sunshin
    Jung, HeeJung
    Han, Sung Hee
    Lee, SeungJae
    Kwon, JeongSub
    Kim, Min Gyun
    Chu, Hyungsik
    Chen, Hongliang
    Han, Kyudong
    Kwak, Hwanjong
    Park, Sunghoon
    Joo, Hee Jae
    Kim, Byung Chul
    Bhak, Jong
    BMC MEDICAL GENOMICS, 2016, 9
  • [6] Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy
    Sunshin Kim
    HeeJung Jung
    Sung Hee Han
    SeungJae Lee
    JeongSub Kwon
    Min Gyun Kim
    Hyungsik Chu
    Hongliang Chen
    Kyudong Han
    Hwanjong Kwak
    Sunghoon Park
    Hee Jae Joo
    Byung Chul Kim
    Jong Bhak
    BMC Medical Genomics, 9
  • [7] Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing EDITORIAL COMMENT
    Zelig, Craig M.
    Knutzen, Dana M.
    Ennen, Christopher S.
    Dolinsky, Brad M.
    Napolitano, Peter G.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2016, 71 (10) : 584 - 585
  • [8] The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992
    Olsen, CL
    Cross, PK
    Gensburg, LJ
    Hughes, PP
    PRENATAL DIAGNOSIS, 1996, 16 (11) : 991 - 1002
  • [9] Uptake, Outcomes, and Costs of Implementing Non-invasive Prenatal Testing for Down Syndrome Into NHS Maternity Care: Prospective Cohort Study in Eight Diverse Maternity Units EDITORIAL COMMENT
    Chitty, Lyn S.
    Wright, David
    Hill, Melissa
    Verhoef, Talitha I.
    Daley, Rebecca
    Lewis, Celine
    Mason, Sarah
    McKay, Fiona
    Jenkins, Lucy
    Howarth, Abigail
    Cameron, Louise
    McEwan, Alec
    Fisher, Jane
    Kroese, Mark
    Morris, Stephen
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2016, 71 (11) : 637 - 639